Initiation of renin-angiotensin system inhibitors and first complete remission in patients with primary nephrotic syndrome: a nationwide cohort study.
Sayaka ShimizuKakuya NiihataHiroki NishiwakiYugo ShibagakiRyohei YamamotoKosaku NittaTatsuo TsukamotoShunya UchidaAsami TakedaHirokazu OkadaIchiei NaritaYoshitaka IsakaNoriaki Kuritanull nullPublished in: Clinical and experimental nephrology (2023)
RASis are beneficial as adjuvant therapy for inducing remission in patients with membranous nephropathy.